Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

24%

5 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (4)
Early P 1 (2)
P 2 (2)
P 3 (3)
P 4 (2)

Trial Status

Unknown7
Recruiting6
Completed4
Not Yet Recruiting2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT04901169Phase 2Active Not Recruiting

Angiotensin II in Liver Transplantation

NCT05058612Phase 4RecruitingPrimary

Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

NCT07345403Not Yet Recruiting

GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.

NCT06952907Not ApplicableRecruiting

Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients

NCT07125443Not ApplicableNot Yet Recruiting

Effect Inhaled Nitric Oxide in Adult Liver Transplant

NCT06615102Phase 3Recruiting

Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II

NCT05833828RecruitingPrimary

Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery

NCT06613256Recruiting

Characterisation of Endothelial Cells in Different Inflammatory Pathologies

NCT05922982Not ApplicableRecruitingPrimary

Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery

NCT04812717Not ApplicableUnknown

Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.

NCT05925348UnknownPrimary

Endotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB)

NCT05199493Phase 3Completed

Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

NCT04964492UnknownPrimary

Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock

NCT05354193Completed

Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery

NCT03744702Early Phase 1CompletedPrimary

Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery

NCT04301479Phase 3UnknownPrimary

Low Dose Corticosteroid Infusion in Vasoplegia After Cardiac Surgery (CORTIVAS-CS)

NCT03968926Unknown

Hypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic Shock

NCT03446599Phase 2WithdrawnPrimary

Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery

NCT02965339UnknownPrimary

Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass

NCT03120637Phase 4Completed

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue

Scroll to load more

Research Network

Activity Timeline